Therapeutic drug monitoring of anti-TNF drugs: an overview of applicability in daily clinical practice in the era of treatment with biologics in juvenile idiopathic arthritis (JIA)

Therapeutic drug monitoring of anti-TNF drugs: an overview of applicability in daily clinical practice in the era of treatment with biologics in juvenile idiopathic arthritis (JIA)

Abstract Background Anti-tumor necrosis factor (TNF) drugs have improved the prognosis for juvenile idiopathic arthritis (JIA) significantly. However, evidence for individual treatment decisions based on serum anti-TNF drug levels and the presence of anti-drug antibodies (ADAbs) in children is scarc...

Full description

Bibliographic Details
Main Authors:	A. Nassar-Sheikh Rashid, D. Schonenberg-Meinema, S. C. Bergkamp, S. Bakhlakh, A. de Vries, T. Rispens, T. W. Kuijpers, G. Wolbink, J. M. van den Berg
Format:	Article
Language:	English
Published:	BMC 2021-04-01
Series:	Pediatric Rheumatology Online Journal
Subjects:	Biologics Anti-TNF drug trough levels Anti-drug antibodies Children Juvenile idiopathic arthritis (JIA)
Online Access:	https://doi.org/10.1186/s12969-021-00545-x

Similar Items

Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registry
by: Giulia Armaroli, et al.
Published: (2020-10-01)

Application of genetically engineered biopharmaceutical products in children with various JIA forms in the Karaganda region
by: Kenzhetaeva Tattigul, et al.
Published: (2024-01-01)

Application of the Yamaguchi criteria for classification of “suspected” systemic juvenile idiopathic arthritis (sJIA)
by: Kumar Sharath, et al.
Published: (2012-11-01)

The effects of TNF-alpha inhibitor therapy on the incidence of infection in JIA children: a meta-analysis
by: Arnold Nagy, et al.
Published: (2019-01-01)

Latent tuberculosis infection screening in juvenile idiopathic arthritis patients preceding anti-TNF therapy in a tuberculosis high-risk country
by: Juliana Barbosa Brunelli, et al.

Incidence, prevalence, and comorbidities of juvenile idiopathic arthritis in Germany: a retrospective observational cohort health claims database study
by: Gerd Horneff, et al.
Published: (2022-11-01)

Correlation analyses of clinical and molecular findings identify candidate biological pathways in systemic juvenile idiopathic arthritis
by: Ling Xuefeng B, et al.
Published: (2012-10-01)

Treat to Target (Drug-Free) Inactive Disease in JIA: To What Extent Is This Possible?
by: Athimalaipet V. Ramanan, et al.
Published: (2022-09-01)

Discordance between Clinical and Ultrasound Examinations in Juvenile Idiopathic Arthritis: An Experimental Approach
by: Francesco Licciardi, et al.
Published: (2022-03-01)

Long Term Experience in Patients With JIA-Associated Uveitis in a Large Referral Center
by: Luca Marelli, et al.
Published: (2021-06-01)

Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis
by: Mia Lindegaard Pedersen, et al.
Published: (2023-09-01)

Prior to extension, Transcriptomes of fibroblast-like Synoviocytes from extended and Polyarticular juvenile idiopathic arthritis are indistinguishable
by: AnneMarie C. Brescia, et al.
Published: (2018-01-01)

Patient characteristics associated with response to NSAID monotherapy in children with systemic juvenile idiopathic arthritis
by: Anjali Sura, et al.
Published: (2018-01-01)

Musculoskeletal pain and its effect on daily activity and behaviour in Icelandic children and youths with juvenile idiopathic arthritis: a cross-sectional case-control study
by: Svanhildur Arna Oskarsdottir, et al.
Published: (2022-07-01)

The Association between PTPN22 Genetic Polymorphism and Juvenile Idiopathic Arthritis (JIA) Susceptibility: An Updated Meta-Analysis
by: Yazhen DI, et al.
Published: (2015-10-01)

Encouraging visual outcomes in children with idiopathic and JIA associated uveitis: a population-based study
by: Mira Siiskonen, et al.
Published: (2023-06-01)

Loeffler’s Endocarditis- A cause of endomyocardial fibrosis in a patient of juvenile idiopathic arthritis: A Case Report
by: Taqdees Khaliq, et al.
Published: (2024-03-01)

Bone mineral density in children with juvenile idiopathic arthritis after one year of treatment with etanercept
by: Sušić Gordana, et al.
Published: (2018-01-01)

Genetic Background and Molecular Mechanisms of Juvenile Idiopathic Arthritis
by: Saverio La Bella, et al.
Published: (2023-01-01)

Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
by: Sonja Falvey, et al.
Published: (2017-06-01)

Foot and Ankle Conventional Radiography in Juvenile Idiopathic Arthritis: Does It Still Matter?
by: Magdalena Posadzy, et al.
Published: (2022-09-01)

Coincidence of selective immunoglobulin A deficiency in juvenile idiopathic arthritis – a series of three cases
by: Paulina Frączek, et al.
Published: (2021-12-01)

Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany
by: Arnd Heiligenhaus, et al.
Published: (2020-04-01)

Persistence on anti-TNF therapy - data from Serbian National Spondyloarthritis Registry
by: Cvetković Jovana, et al.
Published: (2023-01-01)

Lung Involvement in Systemic Juvenile Idiopathic Arthritis: A Narrative Review
by: Duilio Petrongari, et al.
Published: (2022-12-01)

Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics
by: Ping Li, et al.
Published: (2017-07-01)

Antibiotics influence the risk of anti-drug antibody formation during anti-TNF therapy in Chinese inflammatory bowel disease patients
by: Meng Sun, et al.
Published: (2024-04-01)

The risk of depression and anxiety is not increased in individuals with juvenile idiopathic arthritis – results from the south-Swedish juvenile idiopathic arthritis cohort
by: Elisabet Berthold, et al.
Published: (2022-12-01)

Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches
by: Lina N. Zaripova, et al.
Published: (2021-08-01)

Infections and antibiotics during fetal life and childhood and their relationship to juvenile idiopathic arthritis: a prospective cohort study
by: Erik Kindgren, et al.
Published: (2021-09-01)

Heavy metals in fish and its association with autoimmunity in the development of juvenile idiopathic arthritis: a prospective birth cohort study
by: Erik Kindgren, et al.
Published: (2019-07-01)

On the Poetic Features in Jia Zhangke’s Films
by: Zhao Hong
Published: (2019-03-01)

Subtype frequency, demographic features, treatment and outcome of Juvenile Arthritis in one Centre in Abu Dhabi in the United Arab Emirates
by: K. Khawaja, et al.
Published: (2023-02-01)

Effects of anti-TNF biologic drugs on uveitis severity in Behcet patients: systematic review and Meta-analysis
by: Somayeh Abolhasani, et al.
Published: (2022-05-01)

Risankizumab as an effective therapeutic option in severe psoriasis unsuccessfully treated with therapies involving anti- TNF-α and anti-IL-17
by: Michał Adamczyk, et al.
Published: (2020-10-01)

Bilateral Panuveitis at Etanercept Initiation for Juvenile Idiopathic Arthritis
by: Kaouther Ben Abdelghani, et al.
Published: (2014-03-01)

Real-world data reveals the complexity of disease modifying anti-rheumatic drug treatment patterns in juvenile idiopathic arthritis: an observational study
by: Luiza R. Grazziotin, et al.
Published: (2022-04-01)

The effect of etanercept therapy on adrenal steroid metabolism in juvenile idiopathic arthritis: a steroid metabolomics approach
by: Yonatan Butbul Aviel, et al.
Published: (2023-04-01)

In a large Juvenile Idiopathic Arthritis (JIA) cohort, concomitant celiac disease is associated with family history of autoimmunity and a more severe JIA course: a retrospective study
by: Roberta Naddei, et al.
Published: (2022-04-01)

Efficacy of Combined Initial Treatment of Methotrexate with Infliximab in Pediatric Crohn’s Disease: A Pilot Study
by: Yoon-Zi Kim, et al.
Published: (2023-09-01)